4.6 Article

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety

Peter Breining et al.

Summary: Camostat mesylate is a potent inhibitor of the serine protease TMPRSS2, effectively hindering virus-cell membrane fusion and replication, reducing viral load, and potentially improving patient outcomes. Ongoing clinical trials are investigating its potential as an antiviral agent against COVID-19.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Article Infectious Diseases

Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy

Sukbin Jang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19-United States, January-February 2020

Rachel M. Burke et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

News Item Medicine, General & Internal

Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Chemistry, Medicinal

Tackling SARS-CoV-2: proposed targets and repurposed drugs

Siddhi Joshi et al.

FUTURE MEDICINAL CHEMISTRY (2020)

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Physiology

SARS-CoV-2 AND COVID-19: FROM THE BENCH TO THE BEDSIDE

Stefano Romagnoli et al.

PHYSIOLOGICAL REVIEWS (2020)

Editorial Material Medicine, General & Internal

Therapy for Early COVID-19 A Critical Need

Peter S. Kim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Pharmacology & Pharmacy

Protease inhibitors targeting coronavirus and filovirus entry

Yanchen Zhou et al.

ANTIVIRAL RESEARCH (2015)

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Article Biochemistry & Molecular Biology

Dose translation from animal to human studies revisited

Shannon Reagan-Shaw et al.

FASEB JOURNAL (2008)

Review Gastroenterology & Hepatology

Chronic pancreatitis: Evolving paradigms

Rupjyoti Talukdar et al.

PANCREATOLOGY (2006)